Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Y Graeber

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2024
Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftorLena Wucherpfennig, Johanna K Z Becker, Felix Wuennemann, et al.
Annals of the American Thoracic Society|September 10, 2024
Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis From Infancy through AdolescenceMark O Wielpütz, Mirjam Stahl, Simon M F Triphan, et al.
ERJ Open Research|April 3, 2023
Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosisPatricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosisCharlotte O Pioch, Niklas Ziegahn, Christine Allomba, et al.
European Radiology|April 16, 2025
Quantitative MRI detects delayed perfusion and impact of bronchial artery dilatation on pulmonary circulation in patients with cystic fibrosisPatricia Leutz-Schmidt, Julian Grolig, Lena Wucherpfennig, et al.
The European Respiratory Journal|July 6, 2023
Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosisLaura Schaupp, Annalisa Addante, Mirjam Völler, et al.
American Journal of Respiratory and Critical Care Medicine|December 22, 2021
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Constanze Vitzthum, Sophia T Pallenberg, et al.
Frontiers in Medicine|November 28, 2024
Automated lung segmentation on chest MRI in children with cystic fibrosisFriedemann G Ringwald, Lena Wucherpfennig, Niclas Hagen, et al.
Chest|June 5, 2026
Longitudinal Changes in Lung Morphology and Perfusion Detected by Magnetic Resonance Imaging in Patients with Primary Ciliary Dyskinesia From Infancy Through AdulthoodLena Wucherpfennig, Margherita S Silani, Monika Eichinger, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Diane M Renz, Mirjam Stahl, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2024
Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftorLena Wucherpfennig, Johanna K Z Becker, Felix Wuennemann, et al.
Annals of the American Thoracic Society|September 10, 2024
Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis From Infancy through AdolescenceMark O Wielpütz, Mirjam Stahl, Simon M F Triphan, et al.
ERJ Open Research|April 3, 2023
Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosisPatricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosisCharlotte O Pioch, Niklas Ziegahn, Christine Allomba, et al.
European Radiology|April 16, 2025
Quantitative MRI detects delayed perfusion and impact of bronchial artery dilatation on pulmonary circulation in patients with cystic fibrosisPatricia Leutz-Schmidt, Julian Grolig, Lena Wucherpfennig, et al.
The European Respiratory Journal|July 6, 2023
Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosisLaura Schaupp, Annalisa Addante, Mirjam Völler, et al.
American Journal of Respiratory and Critical Care Medicine|December 22, 2021
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Constanze Vitzthum, Sophia T Pallenberg, et al.
Frontiers in Medicine|November 28, 2024
Automated lung segmentation on chest MRI in children with cystic fibrosisFriedemann G Ringwald, Lena Wucherpfennig, Niclas Hagen, et al.
Chest|June 5, 2026
Longitudinal Changes in Lung Morphology and Perfusion Detected by Magnetic Resonance Imaging in Patients with Primary Ciliary Dyskinesia From Infancy Through AdulthoodLena Wucherpfennig, Margherita S Silani, Monika Eichinger, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Diane M Renz, Mirjam Stahl, et al.
Pageof 6